SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/B2CE0CB57630B3BE759A9DF2A660319A62D1C619B68B7BE0F7AA7D4885C6A14F23004C5FA6E6BBBEDF055669614F33A7>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/B2CE0CB57630B3BE759A9DF2A660319A62D1C619B68B7BE0F7AA7D4885C6A14F23004C5FA6E6BBBEDF055669614F33A7
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/B2CE0CB57630B3BE759A9DF2A660319A62D1C619B68B7BE0F7AA7D4885C6A14F23004C5FA6E6BBBEDF055669614F33A7
http://www.w3.org/2000/01/rdf-schema#comment
"CXCL17 attenuates Imiquimod -induced psoriasis-like skin inflammation by recruiting myeloid-derived suppressor cells and regulatory T cells which may be important for regulating excessive inflammation in psoriasis skin."
xsd:string
http://purl.uniprot.org/uniprot/#_1AA0FE53057E1A247A43E4234FA19B2EC4C31981E21A77D197693E8EE1013A1C6EF62255A3CA058327E3136A32D2F6AA
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/B2CE0CB57630B3BE759A9DF2A660319A62D1C619B68B7BE0F7AA7D4885C6A14F23004C5FA6E6BBBEDF055669614F33A7
http://purl.uniprot.org/uniprot/Q5UW37
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B2CE0CB57630B3BE759A9DF2A660319A62D1C619B68B7BE0F7AA7D4885C6A14F23004C5FA6E6BBBEDF055669614F33A7
http://purl.uniprot.org/uniprot/#_Q5UW37-mappedCitation-28389593
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B2CE0CB57630B3BE759A9DF2A660319A62D1C619B68B7BE0F7AA7D4885C6A14F23004C5FA6E6BBBEDF055669614F33A7